Trial Profile

A phase 1 study of TNT119 in membranous nephropathy

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 19 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Nov 2024 According to a Climb Bio media release, the company has completed a Phase 1b trial in pMN and plan to continue the advancement of budoprutug for pMN to late phase development in 2025.
12 Nov 2024 According to a Climb Bio media release, status changed from recruiting to completed.
15 Oct 2024 According to Climb Bio media release, company announced that Full data from this study will be presented in a poster presentation on October 24th at the American Society of Nephrology Kidney Week 2024 being held in San Diego, CA

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com